Ethical considerations in rapid and novel treatments in psychiatry
Neuropsychopharmacology January 1, 2024 Tobias Haeusermann, Winston Chiong
New treatments for mental illness, including psychedelics, ketamine, and neuromodulatory technologies, raise novel ethical questions alongside familiar ones in clinical care and research. This overview examines three key domains of ethical concern: informed consent, the role of expectancy in clinical response, and distributive justice. The authors introduce these issues without presenting empirical findings.